newsfilter
← Latest News
GlobeNewswire·

Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes

SAN DIEGO, May 28, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibrotic therapeutics for a variety of chronic organ